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Clinical trials exploring optimal sedation management in critically ill pediatric patients are urgently needed to
improve both short- and long-term outcomes. Concise operational definitions that define and provide best-
available estimates of sedation-related adverse events (AE) in the pediatric population are fundamental to this
line of inquiry.
Objectives
To perform a multiphase systematic review of the literature to identify, define, and provide estimates of
sedation-related AEs in the pediatric ICU setting for use in a multicenter clinical trial.
Methods
In Phase One, we identified and operationally defined the AE. OVID-MEDLINE and CINAHL databases
were searched from January 1998 to January 2012. Key terms included sedation, intensive and critical care.
We limited our search to data-based clinical trials from neonatal to adult age. In Phase Two, we replicated the
search strategy for all AEs and identified pediatric-specific AE rates.
Results
We reviewed 20 articles identifying sedation-related adverse events and 64 articles on the pediatric-specific
sedation-related AE. A total of eleven sedation-related AEs were identified, operationally defined and
estimated pediatric event rates were derived. AEs included: inadequate sedation management, inadequate
pain management, clinically significant iatrogenic withdrawal, unplanned endotracheal tube extubation, post-
extubation stridor with chest-wall retractions at rest, extubation failure, unplanned removal of invasive tubes,
ventilator-associated pneumonia, catheter-associated bloodstream infection, Stage II+ pressure ulcers and
new tracheostomy.
Conclusions
Concise operational definitions that defined and provided best-available event rates of sedation-related AEs in
the pediatric population are presented. Uniform reporting of adverse events will improve subject and patient
safety.
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The majority of critically ill infants and children supported on mechanical ventilation
receive some form of sedative therapy; most often various combinations of opioids and
benzodiazepines1,2. Although there are clear benefits in using sedation in critically ill
pediatric patients3 sedative use may also be associated with iatrogenic injury4-6. Clinical
trials exploring optimal sedation management in mechanically ventilated pediatric patients
are urgently needed to improve short and long-term outcomes in this vulnerable patient
population.
Fundamental to any clinical trial is patient safety. During the study design phase, anticipated
adverse events (AEs), specific to the patient population and the intervention studied, are
operationally defined and event rates estimated based on best available evidence.
Operational definitions for each AE should be clear and reproducible across multiple clinical
sites. Expected AEs are also incorporated into the study’s risk-benefit profile and informed
consent process. Adverse events are continuously monitored by the investigative team and
Data and Safety and Monitoring Board (DSMB). If an AE rate exceeds that expected then
the study’s risk-benefit burden is reevaluated.
Here, we describe the process used to identify and operationalize sedation-related AEs for
the RESTORE clinical trial. RESTORE (Randomized Evaluation of Sedation Titration fOr
© 2013 Mosby, Inc. All rights reserved.
Corresponding author: Mary Jo C. Grant, APRN, PhD, FAAN, Primary Children’s Medical Center, Pediatric Critical Care, 100 North
Mario Capecchi Drive, Salt Lake City, Utah 84113, Office Phone: 801-662-2442, Office Fax: 801-662-2469, maryjo.grant@imail.org.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
No conflicts of interest.
Published in final edited form as:
Heart Lung. 2013 ; 42(3): 171–176. doi:10.1016/j.hrtlng.2013.02.004.
Respiratory FailurE; U01 HL086622 and U01 HL086649) is a multicenter clinical trial
evaluating the impact of a nurse-implemented goal-directed sedation protocol on clinical
outcomes in pediatric patients with acute respiratory failure. Our objective was to develop
concise operational definitions that defined, and provided best-available event rates, of
sedation-related AEs in the pediatric population.
Methods
We conducted a multiphase systematic review of the literature. Sedation-related AEs were
first identified and operationally defined. Next, each of the operational definitions and event
rates were estimated specific to the pediatric intensive care unit (PICU) population. Adverse
events were defined as “any untoward or unfavorable medical occurrence, including any
abnormal sign or symptom, temporally associated with the use of ICU sedation”7.
Search Strategy
In Phase One we searched the OVID-MEDLINE and CINAHL databases from 1998 – 2008.
Search terms included “sedation”, “intensive care unit” and “critical care”. We limited our
search to English language data-based articles, involving Human subjects across the age
spectrum from neonatal to adult. We included randomized clinical trials, prospective
observational, or pre/post implementation study designs but excluded quality improvement
projects, case reports, surveys, pharmacokinetics studies, and studies evaluating a single
agent. We limited our search to include adverse events related to sedation management and
not those related to a specific sedative or analgesic agents. Reference lists of retrieved
articles were also reviewed. For each publication, we abstracted into data tables: methods,
study population, results, reported operational definitions and event rates for each AE. Data
pooling was not possible because of study heterogeneity. Data saturation was achieved when
no further unique AE or rates of occurrence were identified.
Phase Two replicated our previous search strategy to search terms that included all AEs
identified in Phase One, limited to data-based articles in the pediatric population.
Unpublished data from the RESTORE pilot study (R21 HD045020)8 and available event
rate data from participating sites where added. Pediatric-specific definitions and event rates
were then added to the data table.
Data Extraction and Synthesis
The RESTORE Core Investigator team that included 2 adult and 3 pediatric intensivists, 3
PICU nurses and 1 PICU pharmacist reviewed the data table and, by consensus, made a
recommendation that operationally defined each AE with an expected rate of occurrence.
Excluded from further review at this stage were several phenomena uncommon in pediatrics
(myocardial infarction, delirium), not specific to sedative use (multisystem organ failure),
related to administration techniques (hypotension), unit-based standards of care (urinary
tract infection, restraint use) or evaluated after ICU discharge (post-traumatic stress). Of
note, delirium has not been fully explicated in the pediatric population, valid and reliable
pediatric-specific assessment instruments have only recently been published for verbal
cognitive-capable pediatric patients.
The RESTORE Steering Committee, that included 22 voting pediatric intensivist or
advanced practice nurses representing each participating PICU, then reviewed the data
tables and approved the final terms and rates with 100% agreement. These were then
reviewed and approved by the RESTORE DSMB (see Table One). A replicated systematic
review in January 2012 demonstrated no new AEs that would impact our findings.
Institutional review board was not obtained for this review.
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Results
In Phase One we screened 245 papers (see Figure 1). Of these, 32 articles were retrieved for
more detailed evaluation and 20 met Phase One inclusion/exclusion
criteria9-28_ENREF_9_ENREF_9. As anticipated, none included pediatric patients. 9 were
reported as RCTs, 8 prospective before/after, and 3 prospective, observational. The majority
of studies were conducted in medical ICUs (N=12). Most studies evaluated the effect of
guideline directed sedation management on patient outcomes (N=10).
In Phase Two we included 62 papers to refine our definitions and determine the rates of each
AE in the PICU population. A summary of the sedation-related AEs is provided below.
Anticipated rates for these events are presented in Table One. .
Inadequate sedation management
Achieving adequate and effective sedation levels, and controlling agitation, was evaluated
by most studies in Phase One of this review. In pediatric patients, Fonsmark et al29.
described the efficacy of sedation as” the quality of sedation assessed by the nursing staff;
specifically, the patient is asleep, tolerating mechanical ventilation and able to show a slight
response to nursing procedures”. The COMFORT scale 30was designed to assess distress in
ventilated children but distress was operationalized to include the constructs of both pain
and agitation. From a clinical perspective, separate valid and reliable pain and agitation
assessment tools would allow more targeted therapeutic management.31In 2006, Curley et
al 32 developed then validated State Behavioral Scale (SBS) for use in ventilated pediatric
patients aged 6 wks to 6 yrs. The SBS range is −3 unresponsive to +2 agitated.
In the RESTORE trial, inadequate sedation management was defined as an SBS32 of +1
(restless and difficult to calm) or a SBS of +2 (agitated) for 2 consecutive hours, not related
to a planned extubation attempt.
Inadequate pain management
While a number of studies reported daily or total administration of sedatives and
analgesics 6,17,19,20,23,25,26,33-35 few systematically evaluated the effect of the sedation/
analgesia regimen on a patient’s pain level. A variety of instruments were used to assess
pain. The incidence of pain varied in adult studies ranging from 6-42%21,25.
No pediatric study defined or reported the incidence of inadequate pain management in
mechanically ventilated children. Pain scores of 4 on a 0-10 scale equate to a moderate level
of pain infrequently experienced in nonsurgical patients supported on mechanical
ventilation. Pain assessment tools were based on a 10-point scale. The validated pain
assessment tool depended upon the age and verbal capacity of the subject: infant to 7 years
and nonverbal: FLACC (Facial expression, Leg movement, Activity, Cry, and
Consolability) 36,37; 3+ years of age and verbal: Wong-Baker FACES 38; 5+ yrs of age and
verbal: Numeric Rating Scale; and ≥ 8 yrs and nonverbal: Individualized Numeric Rating
Scale (INRS)39. The RESTORE’s pilot study8 showed the highest median daily pain score
on a 0-10 scale to be 1 (IQR: 1-4).
In the RESTORE trial, inadequate pain management was defined as a pain score > 4 on a
0-10 age appropriate pain scale for 2 consecutive hours, not related to a planned extubation
attempt..
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Clinically significant iatrogenic withdrawal
Iatrogenic withdrawal syndrome related to opioid and or benzodiazepine use has not been
thoroughly described in critically ill adult patients. In contrast, iatrogenic withdrawal
syndrome has been reported to occur in up to 57% of PICU patients40. Iatrogenic
withdrawal is influenced by the length and total exposure to opioids and benzodiazepines,
increasing to over 50% after 5 days of continuous infusion or around-the-clock
administration40,41 and by the rate of weaning29,40,42.
Several assessment instruments have been used to describe iatrogenic withdrawal
syndrome29,42-49. The Finnegan Neonatal Abstinence Score50 (NAS) has been used in
pediatric patients40,43,51,52 defining withdrawal as a NAS of ≥ 8 of 39 for three consecutive
scores obtained every 2 hours51,52 or a NAS of >12 of 3943 or agitation requiring opioid
rescue52. Franck et al. developed the pediatric-specific Withdrawal Assessment Tool 1
(WAT-1)53,54. WAT-1 score of > 3 of 12 is associated with iatrogenic withdrawal.
In the RESTORE trial, clinically significant iatrogenic withdrawal was defined any patient
receiving rescue therapy to manage an increase in WAT-1 score.
Unplanned endotracheal tube (ETT) extubation
Numerous randomized controlled12,13,16,20,24,28,55,56 ENREF 36 and comparative
observational studies 9,18,57-60 report unplanned extubation as a sedation-related AE in adult
patients. Unplanned/self extubation rates in these studies ranged from 1-6 per 100 airway
days.
ENREF 53Factors associated with unplanned extubation in pediatrics include the presence
of agitation61-64 ENREF 55 ENREF 58, high patient/nurse and patient acuity/nurse
ratios 64,65, younger age 63,66,67, medical vs. surgical patients 63, sedation not administered
in the two hours before event 62, lack of two-point or more restraints 62, and performance of
a patient procedure at the bedside62,63. Patients with a longer length of mechanical
ventilation and children in the weaning phase were at a higher risk of unplanned
extubation63. Unplanned extubation rates in pediatrics range from 0.2 to 1.7 per 100 airway
days 62-70. Overall, 14-22% of pediatric patients who self-extubate require re-
intubation 63,71.
Post-extubation stridor with chest-wall retractions at rest
No sedation articles in adults discussed this AE. However, excessive movement of the ETT
within the airway is thought to precipitate airway trauma in the agitated pediatric patient.
The reported pediatric incidence of post-extubation stridor requiring treatment ranges from
15% to 41%72-74. The frequency of pediatric reintubation for stridor ranges from 2% to
52%72-77. Other variables related to stridor included the number of racemic epinephrine
treatments 73,76-80, use of a helium-oxygen gas mixture73, and stridor requiring some form
of intervention74,77. Two RCTs evaluating the use of dexamethasone to prevent post-
extubation stridor reported reintubation in 11%73 and 25%74 of patients with stridor.
The RESTORE trial defined stridor (high-pitched or harsh inspiratory noise) with chest-wall
retractions at rest after ETT extubation to be phenomena of concern.
Extubation failure
In adults, extubation failure was defined as reintubation occurring within 24-48 hours of
extubation16,18,81. The criteria for reintubation was not reported or left to the discretion of
the treating physician. There were significant differences in reintubation rates across study
groups10,13,18. Subjects treated with continuous IV sedation were more likely to require
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reintubation10. Subjects managed with a nurse-implemented sedation protocol were less
likely than the control group to require reintubation 18. Weaning parameters were also found
to be poor predictors of successful extubation82,83.
Reintubation rates in electively extubated pediatric patients ranged from 4-14% 67,71,84-86.
Patients who failed extubation were typically younger 67,85,86, experiencing a longer PICU
length of stay and length of mechanical ventilation 67,76,84-86, were receiving inotropic
support with a low PaO2 87 , or were chronically ill with a respiratory or neurologic
condition77.
Unplanned removal of any invasive tube
Six prospective adult observational studies reported the frequency of unplanned removal of
any invasive tube/catheter 16,21,24,58,60,88. Devices removed included vascular catheters,
bladder catheters, and gastric tubes. Studies implementing systematic pain and sedation
assessments21, daily sedation interruption24 and protocolized sedation16 noted low rates of
device removal. Similar pediatric data were not identified. Unplanned removal of any
invasive tube in RESTORE trial was defined as removal of the device per 100 device days.
Ventilator Associated Pneumonia (VAP)
Five adult studies reported an association between sedation practices and VAP
rates 9,18,21,56,89. The incidence of VAP has been reported to be significantly lower in nurse-
implemented sedation protocol vs. control groups21,18. RESTORE adopted the National
Nosocomial Infections Surveillance System (NNIS)90,91 definition of VAP
Catheter Associated Bloodstream Infection (CA-BSI)
CA-BSI rates may be affected by the use of continuous versus intermittent sedation and/or
the need to enter a central line to administer rescue sedation doses. One adult study reported
a significantly lower rate of CA-BSI in patients managed with a sedation protocol21.
RESTORE adopted the NNIS91,92 ENREF 79 definition of CA-BSI.
Stage two pressure ulcers
Sedated patients cannot communicate nor respond to pressure-related discomfort and thus
are at high risk for pressure ulcers. Adult patients managed with a sedation algorithm
experienced fewer pressure ulcers9. Using the National Pressure Ulcer Advisory Panel
guidelines93, Curley et al94 ENREF 83 reported that 27% of critically ill pediatric patients
developed pressure ulcers. Predictors of pressure ulcers included mechanical ventilation and
lower Braden Q95 ENREF 97scores. RESTORE used the National Pressure Ulcer Advisory
Panel guidelines93 and defined Stage II93 pressure ulcer (or worse) as reportable.
New tracheotomy
Tracheotomy practices differ between adult and pediatric critically ill patients. There is
conflicting evidence on the rate of new tracheotomy in adult patients managed with a
sedation protocol13,14,27,56 ENREF 27. There were no pediatric studies reporting the rate of
new tracheotomy in sedated critically ill patients. We elected to follow all new
tracheotomies as a tracer for extreme airway trauma secondary to agitation.
Discussion
We conducted this systematic literature review to operationally define, summarize and
present a sedation-related AE monitoring plan for the RESTORE multi-institutional clinical
trial. AE definitions and estimated event rates were derived through a multilayered
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consensus process using best available evidence. While clear and concise operational
definitions and estimated rates of specified AE are paramount to the safe conduct of clinical
trials, these data may also be useful to those evaluating patient safety initiatives.
Because of the paucity of pediatric data, pediatric clinicians frequently use data that are
available from adult care. When relevant anatomical or maturational differences exist
between adult and pediatric patients we based our definitions strictly on pediatric literature.
For example, whereas extubation failure is universal, post-extubation stridor is unique in the
pediatric population because of anatomical differences.
Our recommendations must be interpreted in light of several important limitations. The
etiology of sedation related AE appear multi-factorial, and each may be associated with
different risk or protective factors. Sedation practices are rapidly evolving and many papers
now pre-date the trend towards a more awake ICU patient population. Not all tools are
validated to the entire pediatric age spectrum; specifically the SBS was validated in 6 wk to
6 yr olds. While AE rates seem to vary with the use of a sedation protocol, there is
significant heterogeneity among studies and different operational definitions of AE made
comparisons across studies difficult. Careful consideration of the complex interaction
between, age, development, sedation level and exposure, use of protocols and organizational
factors will be fundamental to understanding the factors that alter patient risk. The proposed
definitions and event rates represent a consensus evidence based opinion. Finally, although
our search methods were quite comprehensive, we may have overlooked a relevant paper
that should have been included in our review.
Conclusion
In this article, we propose operational definitions and recommendations for reporting
sedation-related AE in critically ill ventilated pediatric patients. While this work provides
the necessary foundation for the safe conduct of sedation clinical trials, we anticipate
continued dialogue on this topic. These standard definitions may help us communicate,
share results and advance the field.
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Figure One.
Phase One Flow Diagram
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Table 1
RESTORE Specified Events Operational Definitions and Event Rates
Inadequate sedation management: Agitation defined by an SBS > 0 (or “assumed
agitation present” in patients receiving neuromuscular blockade) for 2 consecutive hours
not related to a planned extubation attempt. Event Rate: < 10% of patients
Inadequate pain management: Pain score > 4 (or “assumed pain present” in patients
receiving neuromuscular blockade) for 2 consecutive hours not related to a planned
extubation attempt. Event Rate: < 20% of patients
Clinically significant iatrogenic withdrawal: In patients weaning from ≥ 5 days of
continuous infusion or round-the-clock narcotics, any patient receiving rescue therapy
(defined as an opioid or benzodiazepine bolus or an increase in opioid or
benzodiazepine infusion) to manage an increase in WAT-1 (59) symptoms after the
start of weaning and not for treatment of new pain or sedation needs. Available
evidence identifies iatrogenic withdrawal as a WAT-1 Score of ≥ 3. Event Rate: <75% of
patients
Unplanned endotracheal tube (ETT) extubation: Unplanned extubation. Event Rate <
3.0 per 100 ventilator days
Post-extubation stridor with chest-wall retractions at rest: Stridor (defined as a
high-pitched or harsh inspiratory noise) with chest-wall retractions after ETT extubation.
Event Rate: < 30%
Extubation failure: Reintubation within 24 hours. Less than 10% of patients electively
extubated should require reintubation. Event Rate: < 10% of patients
Unplanned removal of any invasive tube: Unplanned removal of any invasive tube
(e.g., arterial access, central venous access, peripheral venous access, nasogastric
drainage tube, bladder catheter, chest tube, “other” tube). Denominator data are
required to determine accurate rates per 100 days. Event Rate: Unknown
Ventilator-associated pneumonia VAP: Pneumonia occurring ≥48 hours after the
initiation of mechanical ventilation (104) VAP rate as the number of VAP per 1000
ventilator days (92). VAP rates should be zero. All cases of suspected VAP are to be
adjudicated by the local infectious disease officer using a standardized process (105)
and National Healthcare Safety Network definition (106) Event rate: < 3.2 per 1,000
ventilator days
Catheter-associated bloodstream infection CA-BSI: Defined using The National
Nosocomial Infections Surveillance System (NNIS) (100) as the number of CA-BSI per
1,000 days of IV sedative use. CA-BSI rates should be zero. All cases of suspected
CA-BSI are to be adjudicated by the local infectious disease officer using National
Healthcare Safety Network definition (106) Event Rate: < 4 per 1,000 central line days
Stage 2+ pressure ulcers: Stage II (or worse) partial thickness loss of skin layers
involving epidermis and possibly penetrating into but not through dermis. May present
as blistering with erythema and/or induration; wound base moist and pink; painful; free
of necrotic tissue (107). Assign attribution using the Braden Q scale (102). Event Rate:
<30%
New tracheostomy: Track all new tracheostomy as a tracer for extreme airway trauma
secondary to agitation.
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